GlassScriptPhysician profile
Rama Krishna
NPI 1326297813
$5,104.48
in general payments reported to CMS, 2019-2025
32 companies · $386 in 2025
The $386 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $320 · 2021: $1,590 · 2022: $333 · 2023: $1,951 · 2024: $95.36 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,343 · Travel and Lodging: $1,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,343.23 |
| Travel and Lodging | $1,089.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,726.73 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Penumbra, INC. | $995.01 | 2021 | |
| Abiomed | $327.82 | 2021-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $250.04 | 2019-2023 | Farxiga |
| Medtronic Vascular, INC. | $214.18 | 2019-2020 | |
| Amgen INC. | $190.88 | 2019-2020 | |
| Cvrx, INC. | $141.85 | 2021 | |
| Impulse Dynamics (USA) INC. | $141.64 | 2021-2022 | |
| Boston Scientific Corporation | $134.41 | 2025 | Watchman Flx |
| Medtronic, INC. | $119.69 | 2022-2023 | Linq II, Amplia Mri Quad Crt-D Surescan |
| Intuitive Surgical, INC. | $117.12 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $94.38 | 2023 | Uptravi, Opsumit |
| Janssen Pharmaceuticals, INC | $72.27 | 2020-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $59.49 | 2021-2023 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $56.89 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $54.56 | 2021-2023 | Eliquis |
| Terumo Medical Corporation | $48.71 | 2019 | |
| Bardy Diagnostics, INC. | $41.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $37.56 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $29.29 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.76 | 2019-2021 | |
| Atricure, INC. | $25.12 | 2020 | |
| Lantheus Medical Imaging, INC. | $24.54 | 2024 | |
| Biosense Webster, INC. | $23.04 | 2019 | |
| Abbott Laboratories | $22.72 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.53 | 2020 | |
| Sanofi-Aventis U.S. LLC | $20.17 | 2021 | |
| Novo Nordisk INC | $19.96 | 2023 | Rybelsus, Ozempic |
| Alnylam Pharmaceuticals INC. | $19.30 | 2021 | |
| Astellas Pharma US INC | $17.76 | 2019 | |
| Amarin Pharma, INC. | $16.28 | 2022 | |
| Pfizer INC. | $14.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rama Krishna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.